The results of management of 128 consecutive pregnancies occurring in diabetic patients who received insulin from before conception and throughout pregnancy are described. Mean maternal blood glucose levels were at least 1 mmol/litre greater than levels reported in normal pregnancy. Thirty-nine percent of the neonates had significant morbidity; respiratory distress syndrome (7.7%), hypocalcaemia (464%) and polycythaemia (10%) could be related to higher maternal blood glucose levels. Neonatal hypoglycaemia (9-2%), hyperbilirubinaemia (13.8%) and birth weight corrected for gestational age were not directly related to maternal blood glucose. This degree of maternal blood glucose control has reduced the large for dates infants (greater than 90th centile for gestational age) to 7%. Further reduction in the morbidity of infants of diabetic mothers requires studies of physiological maternal blood glucose levels which may not be possible with conventional insulin treatment as well as further efforts to reduce prematurity.
Introduction
Efforts made to control diabetes mellitus during pregnancy together with advances in obstetric and neonatal care have been associated with reduction of perinatal mortality to below 5%. In clinical practice it is not always possible with traditional methods of treatment and monitoring of diabetes to correct all metabolic abnormalities. During pregnancy in nondiabetic women (Gilmer et al., 1975) Relating out-patient maternal blood glucose control to neonatal morbidity (Table 3 ) the levels were significantly higher in those infants subsequently developing respiratory distress syndrome and hypocalcaemia. This was not seen in the corresponding inpatient data for the group with the respiratory distress; the hypocalcaemic neonates were too few to assess statistically. Neonatal polycythaemia was associated with higher in-patient maternal blood glucose levels. Mean maternal blood glucose levels showed no relationship to neonatal hypoglycaemia (Table 3) or to centile birth weight (Table 4 ). In those delivered at 36 or more weeks' gestation there was no correlation of actual birth weight with either in-patient 09.30 hours blood glucose (r = -009) or mean in-patient blood glucose (r= -0'03). There was no apparent greater variation (s.d.) or percentage blood glucose levels greater than 7.5 mmol/litre in the mothers of neonates with morbidity or in the mothers of small or large for dates infants. The distribution of centile birth weight was similar when subdivided into White's classes with no excess of small for dates infants in class D and R.
In the nine pregnancies (7%) with polyhydramnios which was not associated with a major congenital The mean was calculated from the mean blood glucose for an individual pregnancy.
The % of blood glucose levels greater than 7.5 mmol/litre was similarly derived.
group The mean was calculated from the mean blood glucose for an individual pregnancy.
The % of blood glucose levels greater than 7.5 mmol/litre was similarly derived. (Peacock et al., 1979 ). All our outpatient and in-patient mean blood glucose levels are at least 1 mmol/litre greater than corresponding levels in non-diabetic pregnancy (Stubbs et al., 1980) and much more variable as shown by the greater standard deviations.
In a similar series to ours (Leveno et al., 1979) approximately one-half of the neonates had some morbidity which was unrelated to pre-prandial maternal blood glucose levels. 'Our finding of 39% morbidity is comparable but our level of control has eliminated large for dates infants. We were unable to confirm any correlation of blood glucose with birth n(%) 16 (15) 52 (48) 31 (30) 8 (7) weight as reported by Kitzmiller et al. (1978) (Lemons, Vargas and Delaney, 1981) .
It is encouraging that newer insulin infusion systems may be useful in diabetic pregnancy, particularly in avoiding hypoglycaemia which is a constant concern with bolus injections. However, with present techniques of subcutaneous infusion the mean level and variation in blood glucose are not necessarily restored to those found in non-diabetic subjects (Potter, Reckless and Cullen, 1980) . Intensive conventional therapy with multiple insulin injections (Jovanovic et al., 1980) 
